The following articles (labelled with PubMed ID or TBD) are for your review
| PMID | Data | Article Title | Organization |
|---|
| 24900571 |
44 |
Imidazopyridine-Based Fatty Acid Synthase Inhibitors That Show Anti-HCV Activity and in Vivo Target Modulation. |
3-V Biosciences |
| 21726077 |
51 |
The lipogenesis pathway as a cancer target. |
Wayne State University |
| 19223187 |
12 |
Novel fatty acid synthase (FAS) inhibitors: design, synthesis, biological evaluation, and molecular docking studies. |
Institute of Pharmacology and Toxicology |
| 19097781 |
7 |
1-Oxo-3-substitute-isothiochroman-4-carboxylic acid compounds: synthesis and biological activities of FAS inhibition. |
Institute of Pharmacology & Toxicology |
| 16784844 |
44 |
3-Aryl-4-hydroxyquinolin-2(1H)-one derivatives as type I fatty acid synthase inhibitors. |
Merck Research Laboratories |
| 28324785 |
8 |
(-)-UB006: A new fatty acid synthase inhibitor and cytotoxic agent without anorexic side effects. |
Yachaytech University |
Search and Browse
